Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological Predictive Factors of Response to Erythropoiesis Stimulating Agent (ESA) in Low Risk Myelodysplastic Syndromes (MDS) Patients

NCT03598582 is registered in ClinicalTrials.gov with Association pour la recherche sur les Affections Malignes en Immunologie Sanguine as lead sponsor.

NCT NCT03598582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03598582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological Predictive Factors of Response to Erythropoiesis Stimulating Agent (ESA) in Low Risk Myelodysplastic Syndromes (MDS) Patients
Lead sponsor
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2013
Completion date
May 1, 2018
Enrollment
70 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes